About
Continuing Medical Education
Registration
Agenda
Abstracts
Awards
Sponsorship and Exhibits
Hotel
Program Committee
Important Deadlines
Posters
Press
Special Interest Section Meetings
64th-Annual-1920x280

WHO SHOULD ATTEND?

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

AHS has dedicated over 60 years to leading and serving the headache community.

THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premier venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.

HEALTH AND SAFETY

The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event.

All attendees, speakers, and exhibitors are required to be vaccinated against the COVID-19 virus at least 14 days prior to arriving for the event, including recommended booster shots.

When picking up badges, each participant will need to provide proof of vaccination (a vaccine card or a phone picture) with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO). These include Pfizer-BioNTech, Johnson and Johnson’s Janssen, Moderna, AstraZeneca-Oxford, and Sinopharm. If you do not have proof of vaccination during arrival, it could result in delays.

Unvaccinated participants are welcome to still participate in the meeting by registering for the virtual option. Anyone who is registered for in-person attendance and would like to switch to virtual attendance can email AHS at any point.

Masks are required for all participants while inside the meeting space, with the exception of during eating or drinking. Masks are encouraged during outdoor events as well.

Social Distancing will be encouraged and seating during sessions will be spread out to allow for more personal space.

PLENARY PALS PROGRAM

If this is your first time at The Annual Scientific Meeting®, sign up for the Plenary Pals program during registration and to be paired with an experienced attendee who can help guide you through the agenda and meet with you onsite to make sure your experience is fantastic!

 

SPECIAL NOTE FOR THE PHYSICALLY CHALLENGED

The American Headache Society® wishes to take steps to ensure that no individual with a disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Headquarters at 856-423-0043, write to us at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.

64th-Annual-1920x280

PURPOSE/OBJECTIVE

At the conclusion of the program, participants will be able to:

  • Describe novel therapeutic targets for headache disorders and their mechanism of action
  • Utilize headache research techniques to interpret the results of basic science studies and clinical trials
  • Incorporate the role of comorbidities in the management of headache disorders
  • Discuss recent research in post-traumatic headache

 

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this Other (live and recorded sessions) activity for a maximum of 34.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME

  • Please note: The maximum number of credits is calculated based on attending all live sessions and then watching concurrent sessions as recordings later
  • We suggest you wait to complete the evaluation/claim credit until you’ve watched all recording sessions for which credit is sought
  • Complete the post-activity evaluation
  • A certificate of completion will be available once the evaluation is submitted

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received funding to support this activity from the following organizations:

Lilly USA, LLC

64th-Annual-1920x280

REGISTRATION IS NOW OPEN!!

Registration will take place online only. If you need assistance or have multiple attendees from your organization to register, please contact the AHS office.

REGISTRATION CATEGORIES AND FEES*

Early Bird Rate

Before April 8

Regular Rate

April 8 – June 7

Late/Onsite Rate

After June 7

Active Member/Non-Member (MD, DO, PhD, DDS, PharmD) $525/$675 $575/$750 $825/$1,000
Associate Member/Non-Member (RN, NP, PA) $250/$300 $300/$350 $550/$600
AHS Trainee Member/Non-Member $150/$200 $150/$200 $450/$450
Active Military Personnel $450 $450 $500
Industry Representative $675 $750 $1,000

PRE-COURSE REGISTRATION FEES 

Early Bird Rate

Before April 8

Regular Rate

April 8 – June 7

Late/Onsite Rate

After June 7

AHS Member Complimentary Complimentary Complimentary
Non-Member $300 $350 $500

*Prices are for either In-Person or Virtual experiences. All In-Person attendees will also have access to the Virtual experience.

REGISTRATION INFORMATION
Meeting registration includes all educational sessions (except where noted), the exhibit hall, continental breakfast and refreshment breaks each day, as well as several evening receptions during the event.

HEALTH AND SAFETY

The American Headache Society® (AHS) is actively monitoring the health and safety guidance from the Centers for Disease Control as well as state and local health departments. AHS requires attendees to abide by any applicable rules of conduct or local or state laws that may be announced at any time before or during the event, which may include wearing personal protective gear, engaging in social distancing, agreeing to temperature checks or COVID-19 testing requirements, or providing proof of COVID-19 vaccination status.  More information on the health and safety plan for this event will be published closer to the start of the event.

All registrants will have to attest to being fully vaccinated (including recommended booster shots) at least two weeks prior to arriving for the event. Additionally, you may have to produce proof of vaccination when you arrive at the meeting.

FORMS OF PAYMENT

Checks are acceptable when registration is submitted by mail or completed onsite at the 64th Annual Scientific meeting. Checks must be made payable (in US dollars) to the American Headache Society and issued by a US correspondent bank. The registrant is responsible for all bank charges. Mail to:

American Headache Society
2022 Annual Scientific Meeting Registration
19 Mantua Road
Mount Royal, NJ 08061

Credit Cards are the preferred method of payment. AHS accepts Visa, MasterCard, and American Express. AHS reserves the right to charge the correct amount, if different from your calculated total. Charges will appear on your statement as “AHS Registration.”

Wire Transfers are accepted provided that the NET AMOUNT of the wire (after bank fees) is sufficient to cover all registration fees in US dollars. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) for additional information on wire transfer payments.

Cash and Travelers Checks (US dollars only) are accepted for onsite registration at the Annual Meeting. Please do not send cash or traveler’s checks through the mail.

Group Discounts
AHS encourages you and your colleagues to take advantage of the discounted fees available when two or more employees from an organization (same location) register for the meeting. Registration for group discounts must be submitted together. A discount of $25.00 per attendee (after the first attendee pays full price) will be applied. Please contact AHS Registration (856-423-0043 or ahshq@talley.com) to get a discount code for groups.

Letters of Invitation
If requested, the AHS will send a personal invitation for participation at the 64th Annual Scientific Meeting. This invitation is only meant to assist participants in raising travel funds and obtaining a VISA. This is not a commitment on the part of the AHS to provide any financial support.

Cancellation Policy
Requests must be submitted via email no later than Thursday, May 26, 2022. Once the cancellation is processed, all fees paid will be refunded. If paid by credit card, please allow up to five business days for the credit to show in your bank account. THERE WILL BE NO REFUNDS AFTER THE MAY 26th  DEADLINE. 

Substitutions will be accepted until May 26, 2021. For cancelations, substitutions, or experience changes, please contact: ahshq@talley.com

Moving From In-Person Experience To Virtual Experience

Attendees wishing to move from the In-Person to Virtual Experience due to health, inability, or discomfort with traveling may change their registration at any point with no penalty. Please email the AHS office (ahshq@talley.com) to request the change.

64th-Annual-1920x280

Sessions, Speakers, and Times may change.

Thursday, June 9, 2022

6:00 am – 6:30 am Sunrise Yoga
7:00 am – 6:00 pm Registration Desk
7:00 am – 8:00 am Industry-Sponsored Event

Women in Headache Medicine Breakfast

Sponsored by AbbVie, Inc.

Not Eligible for CME Credits

8:00 am – 10:00 am Pre-Meeting Courses
Pre-Course 1: Trials and Tribulations: Optimizing and Expanding Headache Services for Your Patients

Practice Management Committee

 

Moderators: Christina L. Szperka, MD, FAHS; Raissa Villanueva, MD, MPH

8:00 am – 8:05 am Introductions

Christina L. Szperka, MD, FAHS

Children’s Hospital of Philadelphia

 

Raissa Villanueva, MD, MPH

University of Rochester Medical Center

8:05 am – 8:35 am How to Get Involved in Clinical Trials

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

 

Brad C. Klein, MD, MBA

Abington Neurological Associates, LTD

8:35 am – 8:55 am How to Build a Multi-Disciplinary Team

Brian M. Grosberg, MD

Hartford Healthcare Headache Center

8:55 am – 9:05 am Billing/Reimbursement for Psychologists, Working Together

Elizabeth K. Seng, PhD, FAHS

Yeshiva University/Albert Einstein

College of Medicine

9:05 am – 9:15 am Billing/Reimbursement for APPs/RNs and the Logistics of How to Work Together Efficiently

Maureen A. Moriarty, DNP, ANP-BC, FAHS

Moriarty Associates

9:15 am – 9:35 am Prior Authorization- Navigating the Process

Raissa Villanueva, MD, MPH

University of Rochester Medical Center

9:35 am – 9:45 am Special Issues in Pediatrics

Christina L. Szperka, MD, FAHS

Children’s Hospital of Philadelphia

9:45 am – 10:00 am Panel Discussion
   
Pre-Course 2: The Surgical Management of Headache: Cutting Edge Approaches and Controversies

CSF Pressure and Volume Disorders and Procedural Headache Medicine Special Interest Sections

 

Moderator: Paul G. Mathew, MD, DNBPAS, FAHS

8:00 am – 8:25 am ENT Surgical Approaches in Patients with Headache Disorders

Frederick Godley III, MD, FACS

Association of Migraine Disorders

8:25 am – 8:50 am Percutaneous And Surgical Approaches CSF Volume Disorders

Linda Gray Leithe, MD

Duke University Medical Center

8:50 am – 9:15 am Bariatric Surgery and Headache

Jennifer McVige, MD, MA

Dent Neurologic Institute

9:15 am – 9:40 am Nerve Decompression Surgery for the Treatment of Focal Painful Cranial Neuralgias

Pamela Blake, MD, FAHS

Headache Center of River Oaks

9:40 am – 10:00 am Panel Discussion
8:00 am – 12:30 pm Hot Topics in Basic Science Symposium

Moderators: Amynah Pradhan, PhD;

Rami Burstein, PhD

8:00 am – 8:25 am Novel Insights into Migraine Mechanisms From Multi-Modal Minimally Invasive Approach

Andrew C. Charles, MD, FAHS

University of California, Los Angeles

8:25 am – 8:50 am TBA

Andrea Harriott, MD, PhD

Massachusetts General Hospital

8:50 am – 9:15 am Circadian Properties of Cluster Headache Medications and The Trigeminal Ganglion

Mark J. Burish, MD, PhD

University of Texas Health Science Center at Houston

9:15 am – 9:40 am Uncovering a Neuroendocrine Link to Female-Selective Nociceptor Sensitization in Migraine

Caroline Kopruszinski, PhD

University of Arizona

9:40 am – 10:05 am Human and Mouse Trigeminal Ganglia Cell Atlas Implicates Multiple Cell Types in Migraine

William Renthal, MD, PhD

Brigham and Women’s Hospital

10:05 am – 10:20 am Hot Topics Panel Discussion
10:20 am – 10:40 am Break
10:40 am – 11:05 am Brain Functions Altered by Peripherally Acting Drugs

Rami Burstein, PhD

Harvard Medical School

11:05 am – 12:00 pm Data Blitz Presentations

DB-01:  Oxytocin Receptors on Calvarial Periosteal Nociceptors: Pain Modulation in a Model of Post-Traumatic Headache

Vimala Bharadwaj, PhD

Stanford University

 

DB-02: Structure-function Studies of Sodium, Potassium-ATPase Regulators in Migraine

Veronica Hubble, PhD

Huntington Medical Research Institutes

 

DB-03: Pharmacogenomics—One Step Closer to Precision Medicine in Headache? A Pilot, Exploratory Study of the Effect of Pharmacogenomic Phenotypes on the Adequate Dosing of Verapamil for Migraine Prevention

Yi-Chieh Chen, PharmD

Mayo Clinic Health System

 

DB-04: Differential Association of Plasma Hormones with Lipolysis in Chronic Migraine

Alfred Fonteh, PhD

Huntington Medical Research Institute

 

DB-05: Assessing the Mechanistic Processes of Sodium Dysregulation in Migraine Patients

Abush Kolko, BS

University of California, Santa Barbara

 

DB-06: Effects of Goreisan, an Herbal Medicine, on Cortical Spreading Depolarization

Chisato Iba

Keio University School of Medicine

 

DB-07: Sex Differences in Behavioral Reaction in a Rodent Model of Acute Migraine

Chenchen Xia, PhD

Huntington Medical Research Institutes

12:00 pm – 12:30 pm Group Discussion: Future of Basic Science of Headache

Chair: Rami Burstein, PhD

Harvard Medical School

   
10:30 am – 12:30 pm Pacific Rim Symposium

How are CGRP-Related Monoclonal Antibodies Changing Migraine Therapy in the Pacific Rim Countries?

Pacific Rim Committee

 

Moderators: Mamoru Shibata, MD, PhD

 

Overview: How Do We Effectively Utilize CGRP-Related Antibodies in Migraine Prophylaxis?

Mamoru Shibata, MD, PhD

Tokyo Dental College Ichikawa General Hospital

 

Galcanezumab for Difficult-To-Treat Chronic Migraine: Real-World Experience in Taiwan

Yen-Feng Wang, MD, PhD

National Yang-Ming University School of Medicine

 

Monoclonal Antibodies That Work on the CGRP Pathway – The Australian Experience

Michael Eller, MD

Monash Medical Centre

 

Clinical Experience of CGRP Monoclonal Antibodies in Korea

Hong-Kyun Park, MD, MSc

Inje University

 

Real-World Impact of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Japan: A New Era Of Migraine Therapy

Daisuke Danno, MD, PhD

Tominaga Hospital

10:30 am – 12:30 pm Pre-Meeting Courses
Pre-Course 3: The Evidence-Free Zones of Pediatric Headache Treatments

Behavioral Issues, Complementary & Integrative Medicine, and Pediatric & Adolescent Special Interest Sections

 

Moderators: Christina L. Szperka, MD, FAHS; Emily Law, PhD; Niushen Zhang, MD, FAHS

10:30 am – 10:35 am Introductions by the Chairs

Christina L. Szperka, MD, FAHS; Emily Law, PhD; Niushen Zhang, MD, FAHS

10:35 am – 10:55 am Part 1: Treatments for Patients with NDPH and other Continuous Headache Disorders (Medications, CBD, Restrictive Diets, Chiropractic, Surgeries) – Considering Benefits and Harms

Jennifer Hranilovich, MD

Children’s Hospital Colorado

10:55 am – 11:05 am Q&A
11:05 am – 11:35 am Part 2: Lifestyle Advice (Sleep, Hydration, Diet, Screen Time, Exercise), a Debate

 

Lifestyle Recommendations are Beneficial for Headache Care

Lauren Natbony, MD

Icahn School of Medicine at Mount Sinai

 

Lifestyle Recommendations Blame the Patient

Kaitlin Greene, MD

Oregon Health & Science University

11:35 am – 12:00 pm Summary of Lifestyle Recommendations and Q&A
12:00 pm – 12:20 pm Part 3: The State of Research in Pediatric Headache – from Bench to Clinical to Advocacy – Where Have We Been and Where are We Going?

Serena Orr, MD, MS, FAHS

Alberta Children’s Hospital

12:20 pm – 12:30 pm Q&A
 
Pre-Course 4: Understanding Patient-Reported Outcome Measures (PROMs) for Headache Trials and Clinical Practice

Methodology, Design & Statistical Issues Special Interest Section

 

Moderators: Olivia Begasse de Dhaem, MD; Dawn C. Buse, PhD, FAHS

10:30 am – 10:55 am “Fit-for-Purpose” PROMs From a Regulatory Standpoint

Jim McGinley, PhD

Vector Psychometric Group, LLC

10:55 am – 11:20 am Measuring What Matters: Putting the Patient in PROMs

Rikki Mangrum, MLS

Vector Psychometric Group, LLC

11:20 am – 11:45 am Key Quantitative Components Needed for Producing Fit-for-Purpose PROMs

Carrie R. Houts, PhD

Vector Psychometric Group, LLC

11:45 am – 12:10 pm How to Select and Effectively Incorporate PROMs into Clinical Practice and Trials

Richard B. Lipton, MD, FAHS

Albert Einstein College of Medicine

12:10 pm – 12:30 pm Panel Discussion

RJ Wirth, PhD

Vector Psychometric Group, LLC

 

Dawn C. Buse, PhD, FAHS

Albert Einstein College of Medicine

 

Katie Golden

Patient Advocate

12:30 pm – 1:30 pm Industry-Sponsored Event

Patient and Clinician Perspectives in the Use of Modern Therapies for the Management of Migraine

Sponsored by Lilly

CME Eligible (via sponsor)

 

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

 

Stephanie J. Nahas, MD, FAHS

Thomas Jefferson University

 

Stewart J. Tepper, MD, FAHS

Dartmouth-Hitchcock Medical Center

2:00 pm – 2:30 pm      Welcome / Opening Remarks / AMF Update
   
2:30 pm – 3:15 pm      KEYNOTE

Therapeutic Potential of Psychedelics

Bryan Roth, MD, PhD

University of North Carolina

3:15 pm – 4:30 pm PLENARY: Hot Topics in Headache

Moderator: Mark J. Burish, MD, PhD

3:15 pm – 3:20 pm Introductions

Nathaniel M. Schuster, MD

University of California, San Diego

3:20 pm – 3:40 pm Psychedelics and Clinical Trials: What is the Data for Primary Headache Disorders?

Emmanuelle Schindler, MD, PhD

Yale University

3:40 pm – 3:45 pm Q&A
3:45 pm – 4:05 pm How Does the Endocannabinoid System Affect Headache and Disorders?

Tally Largent-Milnes, PhD

University of Arizona

4:05 pm – 4:30 pm Panel Discussion
 
4:45 pm – 5:30 pm AHS Membership Meeting

Not Eligible for CME Credits

 

Board of Directors Transition

Member’s Choice Award

Management of Primary Headaches During Pregnancy, Postpartum, And Breastfeeding: A Systematic Review”

Kenneth K. Chen, MD

Brown University

 

Above and Beyond Awards

Duren Michael Ready, MD, FAHS

Baylor Scott & White Clinic

 

Stephanie J. Nahas, MD, FAHS

Thomas Jefferson University

 

Adam Sprouse Blum, MD

University of Vermont Medical Center

 

Distinguished Service Award

William B. Young, Jr, MD

Thomas Jefferson University

5:30 pm – 6:45 pm Welcome/Exhibitor/Poster Reception
6:45 pm – 7:45 pm Industry-Sponsored Event

A Portfolio of Treatments for Migraine Patients

Sponsored by AbbVie, Inc.

Not Eligible for CME Credits

8:00 pm – 9:00 pm Committee and Section Meetings

 

Friday, June 10, 2022

6:00 am – 6:30 am Sunrise Yoga
6:30 am – 6:00 pm Registration Desk
6:30 am – 8:00 am Committee and Section Meetings
6:30 am – 7:30 am Industry-Sponsored Event

ELYXYB, An Oral Solution for the Acute Treatment of Migraine With or Without Aura

Sponsored by Collegium Pharmaceutical

Not Eligible for CME Credits

 

Andrew Blumenfeld, MD

Headache Center of Southern California

6:30 am – 7:30 am Industry-Sponsored Event

A Guided Discussion AJOVY

The Long-Acting Anti-CGRP Injection with Lasting Protection Against Migraine

Sponsored by Teva

Not Eligible for CME Credits

6:30 am – 8:00 am Exhibits and Posters with Continental Breakfast
8:00 am – 8:45 am Seymour Solomon Award Lecture
Black Patients Matter in Headache Medicine: Exploration of Race, Racism, Race-based Headache Disparities and Professional Ethics

Larry Charleston, IV, MD, MSc, FAHS

Michigan State University College

of Human Medicine

8:45 am – 9:00 am Lifetime Achievement Award
Gretchen E. Tietjen, MD

University of Toledo

9:00 am – 9:15 am NIH Roadmap for Migraine Research Update

Michael L. Oshinsky, PhD

NINDS/NIH

9:15 am – 10:30 am

 

 

9:15 am – 9:35 am

 

 

 

 

9:35 am – 9:55 am

 

 

 

 

 

 

9:55 am – 10:10 am

 

 

 

 

 

10:10 am – 10:25 am

Future of Headache Medicine

 

Clinical Fellowship Award

Implementing Screening and Treatment for Adverse Childhood Experiences in Pediatric Patients with Headache at the Children’s Hospital of Philadelphia

Marissa Anto, MD, MSc

Children’s Hospital of Philadelphia

 

IHA Research Grant Presentation

Examining the Impact of the Sleep-Wake Cycle and Sleep Deprivation on Cortical Spreading Depression Susceptibility and Sensory Sensitivity

Sinifunanya Nwaobi, MD, PhD

University of California, Los Angeles

 

Future Of Headache Medicine

Voluntary Exercise Reduces Acute and Persistent Post-Traumatic Headache-Related Pain in a Rodent Model

Vimala Bharadwaj, PhD

Stanford University

 

Future Of Headache Medicine (FOMH-02)

Presentation of Headache and Its Management in the Emergency Department Amongst a Cohort of Diverse Reproductive Age Women

Crystal Jicha, MD

Montefiore Headache Center

   
10:30 am – 11:15 am Exhibits and Posters with Refreshments
10:30 am – 11:15 am Committee and Section Meetings
11:15 am – 1:00 pm Scientific Paper Presentations – Session 1

Includes Frontiers in Headache Research Scholarship Presentations

11:15 am – 11:25 am OR-01: Migraine Prevalence Has Remained Stable While Disability Has Increased in US Population Studies  

Fred Cohen, MD

Jefferson Headache Center

11:25 am – 11:35 am OR-02: The NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP) Efforts to Validate Rodent Models of Pain and Migraine

Smriti Iyengar, PhD

NINDS/NIH

11:35 am – 11:45 am OR-03: Therapeutic Potential of Cannabinoids on Preclinical Migraine Models

Erik Zorrilla, BS

University of Iowa

11:45 am – 11:55 am OR-04: Resting-State Functional Connectivity in Pediatric Patients With New Daily Persistent Headache

Edina Szabo, PhD

Boston Children’s Hospital, Harvard Medical School

11:55 am – 12:05 pm OR-05: Implementation of a Best Practice Alert in the Electronic Health Record Reduced Neurology Referrals and Magnetic Resonance Imaging for Headache: A Pilot Program of 1,860 Patients

Scott M. Friedenberg, MD

Geisinger Health System

12:05 pm – 12:15 pm OR-06: Validity of Self-Reported Migraine in Adolescents and Children

Danielle J. Kellier, BS

University of Pennsylvania

12:15 pm – 12:25 pm OR-07: Precision Phenotyping in Migraine Using Topological Data Analysis – Visualizing the Spectrum of Migraine Clinical Features

Chia-Chun Chiang, MD

Mayo Clinic

12:25 pm – 12:35 pm OR-08: Symptoms of Increased Peripheral and Central Trigeminal Sensitization Predict the Response to antiCGRP Monoclonal Antibodies: A Multicenter, 24-Week, Cohort Study on 864 Migraine Patients

Gabriella Egeo, MD, PhD

IRCCS San Raffaele Roma

12:35 pm – 1:00 pm Frontiers in Headache Research Scholarship Lecture+ Award Presentation

Mechanisms of Mindfulness’ Impact on Migraine After Mindfulness Based Stress Reduction

Paige Estave, PhD

Wake Forest School of Medicine

 
1:00 pm – 1:30 pm Early Career Award Lecture 
Migraine with Aura Associates with A Higher Artificial Intelligence- ECG Atrial Fibrillation Prediction Model Output Compared to Migraine without Aura in Both Women and Men

Chia-Chun Chiang, MD

Mayo Clinic

1:30 pm – 2:30 pm Exhibits and Poster Session
1:30 pm – 2:30 pm Methodology, Design & Statistical Mentoring Sessions #1
1:30 pm – 2:30 pm Industry-Sponsored Event

Mechanism of Action in Migraine Therapeutics: Does It Matter to Clinicians and Patients?

Sponsored by Lilly

Not Eligible for CME Credits

 

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

 

Peter J. Goadsby, MD, PhD, FAHS

University of California, Los Angeles

 

Paul G. Mathew, MD, DNBPAS, FAHS

Harvard Medical School

2:30 pm – 3:15 pm Harold G. Wolff Award Lecture
Migraine and Peripheral Pain Models Show Differential Alterations in Neuronal Complexity

Amynah Pradhan, PhD

University of Illinois at Chicago

3:15 pm – 5:15 pm PLENARY: Design and Interpretation of Headache Research and Clinical Trials

Moderator: Elizabeth K. Seng, PhD, FAHS

Chair: Jessica Ailani, MD, FAHS

3:15 pm – 3:20 pm Introductions

Robert C. Gibler, PhD

Cincinnati Children’s Hospital Medical Center

3:20 pm – 3:40 pm Animal Modeling of Headache and Design Implementation

Amynah A. Pradhan, PhD

University of Illinois Chicago

3:40 pm – 3:45 pm Q&A
3:45 pm – 4:05 pm The Pitfalls of Unreliable or Missing Data

Dana Turner, PhD, MSPH

Massachusetts General Research Institute

4:05 pm – 4:10 pm Q&A
4:10 pm – 4:30 pm What Should be the Primary Outcome?

R.J. Wirth, PhD

Vector Psychometric Group, LLC

4:30 pm – 4:35 pm Q&A
4:35 pm – 4:55 pm Setting the Criteria for Selection of Clinical Trials

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

4:55 pm – 5:15 pm Panel Discussion
   
5:15 pm – 7:15 pm Friday Evening Events
5:15 pm – 5:45 pm Special Interest Section Fair
5:45 pm – 7:15 pm AHS’ Got Talent
   
7:30 pm – 8:30 pm Industry-Sponsored Event

Treat and Prevent Migraines with an All-in-One Medication

Sponsored by Biohaven Pharmaceuticals

Not Eligible for CME Credits

 

Peter McAllister, MD

New England Institute for Neurology and Headache

 

Saturday, June 11, 2022

 

6:00 am – 6:30 am Sunrise Yoga
6:30 am – 6:00 pm Registration Desk
6:30 am – 7:30 am Industry-Sponsored Event

Starting Today

Effects of a Preventive Treatment Initiated During a Migraine Attack

Sponsored by Lundbeck

Not Eligible for CME Credits

 

Dawn C. Buse, PhD, FAHS

Albert Einstein College of Medicine

 

Rami Apelian, MD, MPH, FAES

Huntington Headache & Neurology

 

Paul K. Winner, DO, FAAN, FAAP, FAHS

Palm Beach Headache Center

6:30 am – 7:30 am Exhibits and Posters with Continental Breakfast
7:30 am – 9:30 am Industry-Submitted Abstracts

Not Eligible for CME Credits

7:30 am – 7:40 am IOR-01: Efficacy And Safety Of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial

Kathleen Mullin, MD

New England Institute for Neurology and Headache

7:40 am – 7:50 am IOR-02: Incidences of Traumatic Brain Injury and Post-Traumatic Headache for all Age Groups Using a US Claims Database

Juline Bryson, MD

Teva

7:50 am – 8:00 am IOR-03: Migraine-Related Stigma and Its Influence on Disability, Interictal Burden, and Migraine Specific Quality of Life: Results of the OVERCOME (US) Study

Robert E. Shapiro, MD, PhD

Larner College of Medicine, University of Vermont

8:00 am – 8:10 am IOR-04: Increased Placebo Response Over Time in Oral Migraine Preventive Trials: A Systematic Literature Review and Meta-Analysis

Stewart J. Tepper, MD, FAHS

Dartmouth-Hitchcock Medical Center

8:10 am – 8:20 am IOR-05: Characterizing Preventive Treatment Gaps in Migraine: Interim Results From the CaMEO-International Study United States Sample

Dawn C. Buse, PhD, FAHS

Albert Einstein College of Medicine

8:20 am – 8:30 am IOR-06: Cardiovascular Outcomes Associated With Oral Triptans Among Migraine Patients With a History of Cardiovascular Conditions

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

8:30 am – 8:40 am IOR-07: A Multicenter, Open Label Study Assessing the Efficacy of AJOVY® (fremanezumab-vfrm) on Interictal Migraine Related Burden

Heather Manley, MS, LPC
Clinvest Research

8:40 am – 8:50 am IOR-08: Long-Term Safety and Tolerability of STS101, a Dry Powder Intranasal Dihydroergotamine Product:  Initial Data From the ASCEND Study

Stewart J. Tepper, MD, FAHS

Dartmouth-Hitchcock Medical Center

8:50 am – 9:00 am IOR-09: Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Study

Richard B. Lipton, MD, FAHS
Albert Einstein College of Medicine

9:00 am – 9:10 am IOR-10: Early Prediction of Response to INP104 for the Acute Treatment of Migraine

Sara E. Sacco, MD

Carolinas Headache Clinic

9:10 am – 9:20 am IOR-11: Decrease in Body Weight With Once-Daily Atogepant for the Preventive Treatment of Migraine: A Post Hoc Analysis

Jessica Ailani, MD, FAHS

MedStar Georgetown University Hospital

9:20 am – 9:30 am IOR-12: Celecoxib Oral Solution in the Acute Treatment of Migraine: Pooled Efficacy and Safety Results From 2 Randomized Placebo-controlled Trials

Todd Kunkel
Collegium Pharmaceutical

   
9:30 am – 10:00 am Coffee Break
10:00 am – 10:45 am DEBATE: Positive Phase 3 Trial: ‘So what?’ OR ‘That’s awesome!’ Are Clinical Trials Representative of our Patients?

Chairs: Christina L. Szperka, MD, FAHS; Deborah I. Friedman, MD, MPH, FAHS

 

Jan L. Brandes, MD

Nashville Neuroscience Group

 

Amy Gelfand, MD, FAHS

University of California, San Francisco

10:45 am – 11:15 am Exhibits and Posters with Refreshments
   
11:15 am – 12:15 pm CONCURRENT SESSION

Scientific Paper Presentations – Session 2A

11:15 am – 11:25 am OR-09: Injection of CGRP in the Medial Cerebellar Nucleus Alters Sensory but Not Motor Behaviors

Thomas Duong

University of Iowa

11:25 am – 11:35 am OR-10: Efficacy of a Dual ENKephalinase Inhibitor in a Preclinical Stress-Induced Migraine Model

Hao-Ruei Mei

University of Texas at Dallas

11:35 am – 11:45 am OR-11: Migraine During Fertility Treatment: Interim Analysis of a Pilot Study

Joseph Safdieh

Weill Cornell Medicine

11:45 am – 11:55 am OR-12: Sex Differences in Migraine: A Twin Study

Morgan C. Fitzgerald, BS

University of California San Diego

11:55 am – 12:05 pm OR-13: The Migraine Disability Assessment (MIDAS) as an Indicator of Resilience in Patients with Headaches

Deborah I. Friedman, MD, MPH, FAHS

University of Texas Southwestern

12:05 pm – 12:15 pm OR-14: There is No Sleeping it Off: The Impact of Poor Sleep in Children with Headache

Deirdre A. Caplin, PhD

University of Utah

11:15 am – 12:15 pm CONCURRENT SESSION

Scientific Paper Presentations – Session 2B

Includes Late-Breaking Abstract Presentations

11:15 am – 11:55 am Late-Breaking Abstracts
11:45 am – 11:55 am OR-15: A Case-Control Study of Continuous Headache in Youth with Migraine, Persistent Post-Traumatic Headache, and New Daily Persistent Headache

Carlyn A. Patterson Gentile, MD, PhD

Children’s Hospital of Philadelphia, University of Pennsylvania

11:55 am – 12:05 pm OR-16: Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data

Seonkyeong Yang, MS

University of Florida

12:05 pm – 12:15 pm OR-17: Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of Recurrence

Juliana VanderPluym, MD

Mayo Clinic Arizona

12:15 pm – 1:00 pm DEBATE: Is Inflammation a Mechanism of Migraine?

Chair: Andrew F. Russo, PhD

 

Dan Levy, PhD, MSc

Beth Israel Deaconess Medical Center

 

Andrew C. Charles, MD, FAHS

University of California, Los Angeles

1:00 pm – 2:15 pm Exhibits and Poster Session
1:00 pm – 2:15 pm Methodology, Design & Statistical Mentoring Sessions #2
1:00 pm – 2:00 pm Industry-Sponsored Event

Setting the bar higher:  Think you know DHE?  Think again.

Sponsored by Impel Pharmaceuticals

Not Eligible for CME Credits

 

Sara E. Sacco, MD

Carolinas Headache Clinic

 

Deborah I. Friedman, MD, MPH, FAHS

University of Texas Southwestern

2:15 pm – 3:45 pm Scientific Paper Presentations – Session 3

Includes Frontiers in Headache Research Scholarship

2:15 pm – 2:25 pm OR-18: Migraine Classification Using Deep Learning on Structural Brain MRI Data

Mahfuzur Rahman Siddiquee

Arizona State University

2:25 pm – 2:35 pm OR-19: Anxiety and Depressive Symptoms and Disorders in Children and Adolescents with Migraine: A Systematic Review and Meta-Analysis

Serena L. Orr, MD, MSc

Alberta Children’s Hospital

2:35 pm – 2:45 pm OR-20: Validation of Measures of Treatment Expectancy in Children & Adolescents with Headache

Christina Szperka, MD

Children’s Hospital of Philadelphia

2:45 pm – 2:55 pm OR-21: The Unique Role of Stigma in Migraine-Related Disability and Quality of Life

Elizabeth K. Seng, PhD

Albert Einstein College of Medicine

2:55 pm – 3:05 pm OR-22: Glial Activation in Pain and Emotional Processing Regions in a Mouse Model of Chronic Migraine

Haley C. Cropper, BS

University of Illinois at Chicago

3:05 pm – 3:15 pm OR-23: Examining the Test-Retest Consistency of Sensory Hypersensitivity Measures in Headache Subjects

Eric Tokita

University of Utah

3:15 pm – 3:25 pm TBD Presentation
3:25 pm – 3:35 pm Frontiers in Headache Research Scholarship Presentation

Exploring the Neurobiology of the Premonitory Phase of Migraine Preclinically: Possible Involvement of Hypothalamic Kappa Opioid Receptor (KOR) Signaling

Caroline Kopruszinski, PhD

University of Arizona

3:35 pm – 3:45 pm Frontiers in Headache Research Scholarship Presentation

Headache Disability in Children and Adolescents Before and During The COVID-19 Pandemic

Brian LaGrant, MD

Children’s Hospital of Philadelphia

3:45 pm – 5:45 pm PLENARY: What Makes Migraine Worse

Moderator: Dawn C. Buse, PhD, FAHS

Chair: Amynah A. Pradhan, PhD

3:45 pm – 3:50 pm Introductions

Eric A. Kaiser, MD, PhD

University of Pennsylvania

3:50 pm – 4:10 pm Sleep

Emily Law, PhD

University of Washington

& Seattle Children’s Hospital

4:10 pm – 4:15 pm Q&A
4:15 pm – 4:35 pm Medication Overuse

Todd J. Schwedt, MD, MSCI, FAHS

Mayo Clinic – Arizona

4:35 pm – 4:40 pm Q&A
4:40 pm – 5:00 pm Obesity

Dale S Bond, PhD

Hartford Hospital/HealthCare

5:00 pm – 5:05 pm Q&A
5:05 pm – 5:25 pm Psychiatric Comorbidities

Todd A. Smitherman, PhD, FAHS

University of Mississippi

5:25 pm – 5:45 pm Panel Discussion
 
5:45 pm – 6:30 pm John R. Graham Award Lecture
Peter J. Goadsby, MD, PhD, FAHS

University of California, Los Angeles

6:30 pm – 7:30 pm Wine and Cheese Reception

 

Sunday, June 12, 2022

7:00 am – 10:00 am Registration Desk
7:00 am – 8:00 am Continental Breakfast
8:00 am – 10:00 am PLENARY: TBI/Post Traumatic Headache

Moderator: Alan G. Finkel, MD, FAHS

Chair: Catherine D. Chong, PhD, FAHS

8:00 am – 8:05 am Introductions

Carlyn Patterson Gentile, MD, PhD

Children’s Hospital of Philadelphia

8:05 am – 8:25 am TBD Basic Science Talk

K.C. Brennan, MD

University of Utah

8:25 am – 8:30 am Q&A
8:30 am – 8:50 am TBD Talk

Catherine D. Chong, PhD, FAHS

Mayo Clinic – Arizona

8:50 am – 8:55 am Q&A
8:55 am – 9:15 am Epidemiology and a Focus on VA Data

Jason Sico, MD, MHS

Veterans’ Health Administration

9:15 am – 9:20 am Q&A
9:20 am – 9:40 am Clinical Perspective on PTH

Tad Seifert, MD

Norton Healthcare

9:40 am – 10:00 am Panel Discussion
64th-Annual-1920x280

The late-breaking abstract site is now closed.

Authors will receive acknowledgment of receipt of abstracts via email and notification regarding acceptance on or before May 13, 2022.

Abstract FAQs

Do I need to indicate that my abstract has been submitted to other meetings/journals?
Yes. If the data submitted has been presented in total or in large part in the past, please note the date and place of the previous presentation(s).

Do you have an anticipated time for when abstract decisions will be sent out?
Notifications for late-breaking abstracts will go out by May 13, 2022.

Can I get an extension on the abstract submission deadline?
Due to the review process and timeline, extensions are not permitted.

Is there an abstract submission fee?
No, there is no submission fee.

Do you accept industry abstracts?
Yes. Industry abstracts need to be identified and are not eligible for CME credits. Abstracts submitted by industry will be considered in separate categories from other abstracts. Industry abstracts fall into two categories:
1) Industry-initiated Clinical Trials
2) industry-initiated Research Involving Drugs, Devices, or other Products with a Commercial Interest. This category will not include investigator-initiated studies that may have industry support.

Will abstracts be published? If yes, when and where?
Accepted abstracts will be published in the journal, Headache®. They are typically in the June edition or sent as a supplement to the June edition.

Is there a limit on how many abstracts an author can submit or present?
No, there is no limit. However, for industry abstracts from the same study, we strongly recommend combining them into fewer abstracts.

Do you allow encores?
Yes. You can submit an abstract that has previously been presented within the last year as long as it is the same data and information. All “Encore” submissions will be reviewed by the selection committee and authors will be notified if they have been accepted.

What is the embargo policy?
All content and data is embargoed until June 8, 2022 @11:59 pm MT.

When and where can I view abstracts?
Abstracts will be available to view in the mobile app and in the journal, Headache®.

Are there text abstracts available?
Yes, in the journal, Headache®.

When will AHS abstracts be publicly available?
They are available starting June 9, 2022 @ 12am MT. They will be published in the journal, Headache®, as well as through the meeting’s mobile app.

How do I register for the meeting?
All accepted abstract lead/presenting authors will receive a special set of instructions with their acceptance notice including information on how to register for the meeting.

Are lead/presenting authors required to register for the meeting?
If you plan to present at the meeting (either in-person or virtually), you must register for the meeting.

What if the lead/presenting author cannot attend the meeting?
If this arises, AHS will allow one of the other authors to register and present on their behalf.

Do poster presenters need to register for the meeting?
Yes, poster presenters must register.

AHS Policy on Industry Submitted Abstracts (PDF)

Still have questions? Please click here to contact AHS Headquarters via email.

64th-Annual-1920x280

CONGRATULATIONS TO THE 2022 ANNUAL AWARD RECIPIENTS!

 

Above & Beyond Awards

Stephanie J. Nahas, MD, MSEd, FAHS
Thomas Jefferson University
Philadelphia, Pennsylvania
Duren Michael Ready, MD, FAHS
Baylor Scott & White Clinic
Temple, Texas
Adam Sprouse Blum, MD
University of Vermont Medical Center
Burlington, Vermont

Distinguished Service Award

William B. Young Jr., MD, FAHS
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania

Join us during the AHS Membership Meeting on Thursday, June 9 from 4:45 – 5:30 PM MDT in Adams A for Above and Beyond and Distinguished Service award presentations.

View additional Above and Beyond Award information here

View additional Distinguished Service Award information here.

 

Seymour Solomon Lecture Award

Larry Charleston IV, MD, MS, FAHS
Michigan State University College of Human Medicine
East Lansing, Michigan

 Join us on Friday, June 10 from 8:00 – 8:45 AM MDT in Adams A for the Seymour Solomon lecture and award presentation.

View additional Solomon Award information here.

 

Lifetime Achievement Award

Gretchen E. Tietjen, MD
University of Toledo
Toledo, Ohio

Join us on Friday, June 10 from 8:45 – 9:00 AM MDT in Adams A for the Lifetime Achievement award presentation.

View additional Lifetime Achievement Award information here.

 

Early Career Award

Chia-Chun Chiang, MD
Mayo Clinic
Rochester, Minnesota

Join us on Friday, June 10 from 1:00 – 1:30 PM MDT in Adams A for the Early Career lecture and award presentation.

View additional Early Career Award information here.

 

Harold G. Wolff Award

Amynah Pradhan, PhD
University of Illinois at Chicago
Chicago, Illinois

Join us on Friday, June 10 from 2:30 – 3:15 PM MDT in Adams A for the Harold G. Wolff lecture and award presentation.

View additional Wolff Award information here.

 

John R. Graham Lecture Award

Peter J. Goadsby, MD, PhD, FAHS
University of California, Los Angeles
UCLA Goldberg Migraine Program
Los Angeles, California

Join us on Saturday, June 11 from 5:45 – 6:30 PM MDT in Adams A for the John R. Graham lecture and award presentation.

View additional Graham Award information here.

 

“Frontiers in Headache Research” Scholarship Awards

Platform Presenters:
Paige Estave, PhD
Wake Forest School of Medicine
Winston Salem, North Carolina
Caroline Kopruszinski, PhD
University of Arizona
Tucson, Arizona
Brian LaGrant, MD
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
Poster Presenters:
Mai-Lynn Bui, DO
University of South Florida
Tampa, Florida
Jay Dave, DO
Rutgers Robert Wood Johnson University Hospital
East Windsor, New Jersey
Andrew Day, MD
NYU Langone Medical Center
New York, New York
Lucia Liao, MD
Thomas Jefferson University
Philadelphia, Pennsylvania
Riya Luhar, DO
Hartford Healthcare Headache Center
Windsor, Connecticut
Katrina Nayak, MD
University Hospitals/Case Western Reserve
Cleveland, Ohio
Ann Oh, MD
University of Colorado Anschutz Medical Campus
Denver, Colorado
Peter Soh, MD, MPH
Hartford Healthcare Headache Center
Hartford, Connecticut

Join us on Friday, June 10 from 11:15 AM – 1:00 PM MDT in Adams A for scholarship and award presentations during Scientific Paper Presentations – Session 1.

 Join us on Saturday, June 11 from 11:15 AM – 12:15 PM MDT in Adams A for scholarship presentations during Scientific Paper Presentations – Session 2B and from 2:15 pm – 3:45 PM during Scientific Paper Presentations – Session 3.

View additional “Frontiers in Headache Research” Award information here.

 

Runnin’ for Research Advocacy Awards

Attending the 64th Annual Scientific Meeting:
Anastasia Railean, MD
Wake Forest Atrium Health
Lewisville, North Carolina
Attending the 2022 Scottsdale Headache Symposium®:
Jessalyn Shen, MD
Montefiore Medical Center
Bronx, New York

AVAILABLE OPPORTUNITIES

Association of Migraine Disorders Travel Grant

This program reimburses travel expenses for those attending a scientific meeting or symposium related to migraine.

Eligibility requirements 

  • undergraduate, graduate student or postdoctoral researcher
  • the educational program must be registered in the United States
  • priority will be given to those who present a poster/oral presentation at the meeting

Value of Grant: limited to $500 USD

Instructions

Complete the short application form via THIS LINK
Upload your current CV and a letter from your advisor or PI confirming your good standing in the program (in the form)
Join the Migraine Science Collaborative (www.migrainecollaborative.org) if you are not already a member

Requirements for reimbursement after the event

Submit proper receipts accounting for all expenses.
Presentation at event to acknowledge AMD as grant provider

Application deadline: May 4, 2022

Learn more and apply.

64th-Annual-1920x280

SPONSORSHIP AND EXHIBIT INFORMATION

The Sponsorship Portal is now open! Visit to book your support today!

View the Sponsorship and Exhibit Prospectus
View the Exhibit Hall Floor Plan
View Exhibit Hall Hours

 

NEW SPONSORSHIP OPTIONS FOR 2022:

  • Hydration Package: Place your logo on a branded metal water bottle given to all attendees. Reduce waste and create an item that will be reused. AHS will produce these items.
  • AHS Has Talent Sponsorship: Become the key sponsor for the AHS Talent Show on Friday night. Feature your logo on stage and in the program as meeting attendees showcase their secret talents (also features light refreshments).
  • In House-TV: Put your company on TV! Use the hotel’s In-Room TV channel to provide excellent coverage for your company and products. Get creative with a 72-hour loop (Thur-Sat) of your content playing in every hotel room.
  • Wellness Sponsor: Help attendees start the day on the right foot by sponsoring our new sunrise yoga sessions. This includes a gift of a branded yoga mat that each attendee takes home.
  • *NEW* Industry-Sponsored Symposium First Choice: This exclusive Industry Symposium sponsorship will guarantee you your first choice of time/dates (from the AHS provided list). You will also receive extra promotions throughout the conference space. Use our Exhibit and Sponsorship portal to select a sponsorship opportunity (booth included) or purchase an exhibit booth without sponsorship. You can also purchase additional sponsorship opportunities.

ALSO NEW FOR 2022

Submitting your applications for industry events and ancillary meetings is easier! All submissions and payments can be made directly in the exhibit and sponsorship portal. Simply select the industry or ancillary event as an item to purchase and then complete the necessary “tasks” in the portal. Once the tasks are completed and your application is approved, you will be notified and sent an invoice to complete directly in the portal.

INDUSTRY SUPPORTED EVENTS

Add your organization to those sharing research and product news with a Satellite Symposium. We have openings from Thursday to Saturday. These events take place without conflict of other CME sessions and will be advertised in the Final Program.

You can offer a presentation with or without CME (you will be responsible for securing your own CME provider) and choose to serve food in your private room with space for over 100 attendees. You must have an FDA-approved product/service.

View CME Event Objectives & Guidelines here
View Non-CME Event Policy & Guidelines here

 

If you are not exhibiting or sponsoring the meeting but would like to request space for a meeting, please contact Heidi Jetter at hjetter@talley.com.

 

The American Headache Society gratefully acknowledges the support of the 64th Annual Scientific Meeting from our industry supporters:

PLATINUM

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illness by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Biohaven Pharmaceuticals logo

Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases. The Company has two small molecule calcitonin gene-related peptide (CGRP) receptor antagonist product candidates in development, rimegepant and vazegepant, for acute and preventive treatment of migraine. Rimegepant, the lead candidate, is an orally-administered, rapidly dissolving single dose CGRP with a novel mechanism that targets the underlying pathophysiology of migraine without causing vasoconstriction.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission.

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health.

GOLD


Axsome Therapeutics, Inc. is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.

SILVER

      Satsuma Logo    Teva logo      Upsher-Smith logo

 

AHS gratefully acknowledges the educational grant support of the 64th Annual Scientific Meeting from our industry supporters:

Lilly USA, LLC
64th-Annual-1920x280

HOTEL

Gaylord Rockies Resort
6700 N. Gaylord Rockies Blvd
Denver, CO
Photo of Gaylord with Rocky Mountains behind

Standing at the edge of the Front Range, Gaylord Rockies Resort & Convention Center showcases the state’s alpine charm and offers guests a welcome reprieve from the typical mountain resort stay. From our thrilling Arapahoe Springs Water Park, to an exciting lineup of family-friendly activities and entertainment, there’s something for the entire family to enjoy. Guests can explore the beautiful Grand Lodge and its stunning mountain views, five delicious restaurants, bars, the world-class Relâche Spa, and a state-of-the-art fitness center. With a fantastic water park, seasonal events, entertainment, and close proximity to local attractions, Gaylord Rockies Resort is the place where you can enjoy more of everything you love.

The group room rate at the Gaylord Rockies Resort for AHS participants is $249.00 for a single or double room, plus prevailing taxes.  Room reservations and rates are available on a first-come, first-served basis until Thursday, May 12, 2022, or until the room block is sold out, whichever comes first. After that date, reservation requests will be based on the hotel’s prevailing rate. All reservations must be guaranteed with a credit card. There is a special link to book your room in the registration confirmation email. 

Reservations within the AHS block of rooms are for registered attendees ONLY. Reservations made by non-registrants will not receive the discounted rate and may be canceled.

64th-Annual-1920x280

Scientific Program Committee

Chair

Amynah Pradhan, PhD
University of Illinois at Chicago
Chicago, Illinois

Committee Members

Jessica Ailani, MD, FAHS
MedStar Georgetown University Hospital
Washington, District of Columbia
Andrew Russo, PhD
University of Iowa
Iowa City, Iowa
Mark J. Burish, MD, PhD
University of Texas Health Science Center at Houston
Houston, Texas
Elizabeth Seng, PhD, FAHS
Yeshiva University/Albert Einstein College of Medicine
Bronx, New York
Catherine D. Chong, PhD, FAHS
Mayo Clinic
Phoenix, Arizona
Christina L. Szperka, MD, FAHS
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania
Deborah I. Friedman, MD, MPH, FAHS
UT Southwestern Medical Center
Dallas, Texas
Juliana VanderPluym, MD, FAHS
Mayo Clinic
Phoenix, Arizona
64th-Annual-1920x280

Below are a list of important dates and deadlines for the 64th Annual Scientific Meeting. Please contact the AHS Team (ahshq@talley.com) with any questions:

  •  Registration
    • Early-Bird: Before April 8
    • Regular Registration: April 8 – June 7
    • Late Registration: June 8 – June 12
  • Hotel
    • Last day to guarantee the AHS group rate: May 12
  • Scientific Abstracts
    • Abstract submissions close on February 17, 2022, 11:59 pm Hawaii Standard Time (February 18, 2022, 4:59 am Eastern Standard Time)
    • Submissions acceptance notices sent by April 1, 2022
  • Frontiers in Headache Research Scholarship Awards
    • Call for applications opens: January 10, 2022
    • Application deadline: February 28, 2022
  • Runnin’ for Research Advocacy Award
    • Call for applications opens: January 31, 2022
    • Application deadline: March 7, 2022
  • Members’ Choice Award
    • Call for votes opens: March 1, 2022
    • Voting deadline: March 31, 2022
64th-Annual-1920x280

Congratulations to those abstracts accepted as posters. We know this is an exciting time and that you may have questions.  Please read the FAQ’s below:

How Do I Accept My Invitation to Present a Poster?

Please look for the link in our email to you.  Use that to login to our Poster Collection Platform and accept our invitation. You will also use this platform to upload a digital copy of your poster. We will use this on the mobile app and virtual event website. Please accept your poster presentation by Friday, April 15, 2022.

Are Presenting Authors Required to Register for the Meeting?

If you plan to present/defend your poster at the meeting, you must register. All accepted abstract presenting authors will receive instructions with their acceptance notice with information on how to register for the meeting.

What if I Can’t Be There in Person?

We understand that not everybody can join us in Denver. Therefore, if you choose the Virtual Attendance Experience, you can still have one of your colleagues hang your physical poster. However, you will not have the opportunity to answer live questions from the attendees.

Is There a Discount for Poster Authors?

Yes, presenting authors can take advantage of an extended early bird rate until April 15. When entering the Poster Collection Portal, look for the “Registration” task.

How Do I Book My Hotel Room?

After you register, you will receive a link to book a hotel room in your registration confirmation email. The hotel cut-off is May 13 at 5 pm MT or until the block sells out, whichever comes first.

When Can I Hang My Poster/When Does it Have to Come Down By?

Posters should be hung on the assigned board between 2:00 pm – 4:00 pm on Thursday, June 9. Posters should not be removed before 2:30 pm on Saturday, June 11. Any poster left after 5:00 pm on Saturday, June 11, may be discarded.

When Should I be at my Poster for the Q & A Session?

Poster presenters with an ODD Poster number should be available at their poster between 1:30 pm – 2:30 pm on Friday, June 10. Poster presenters with an EVEN poster number should be available between 1:00 pm – 2:15 pm on Saturday, July 11.

How Can I Print and Ship My Poster?

AHS is offering a special poster printing opportunity via MakeSigns.

This includes discounted printing prices and free shipping of your poster to the meeting venue or your office. Although this is not mandatory, we suggest you take advantage of this service.

  • The benefits of using the poster printing program include:
  • The poster can ship to the meeting. Pick it up onsite and avoid the inconvenience of carrying it to the meeting.
  • Free templates are available for download to make the poster creation process easy.
  • Customer support is available to assist with questions.

Please note if you select to print your poster via MakeSigns, you will still need to be present to mount your poster.

To take advantage of our special package, click here.

If you want to print the poster with another company, please use these guidelines

  • Recommended poster size: 72″W x 36″H
  • MAX poster size: 91″W x 45″H
  • Poster board space: 96″W x 48″H (8′ x 4′)
  • Media Type: No restrictions (presenters can choose matte, glossy or fabric)

To ship your poster directly, please address it like this:
Gaylord Rockies Resort & Convention Center
Hold for Guest: (Guest Name) (Arrival Date)
(Guest Cell Number)

6700 N. Gaylord Rockies Blvd
Aurora, CO 80019

64th-Annual-1920x280

Welcome to the American Headache Society’s64th Annual Scientific Meeting Press Room. Here you can find the latest news releases related to the meeting, as well as press guidelines for media professionals, exhibitors, presenters and satellite symposia organizers.

Please contact the American Headache Society for all media-related questions, including obtaining press passes, at ahshq@talley.com or 856-423-0043.

AHS Press Guidelines

64th-Annual-1920x280

Please check back soon for the Special Interest Section Meeting schedule.